---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-018123"
form_type: "8-K"
ticker: "PRPH"
cik: "0000868278"
company_name: "ProPhase Labs, Inc."
filed_at: "2025-10-15T23:59:59+00:00"
generated_at: "2026-05-17T03:49:19.853199+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# ProPhase Labs enters into ATM equity offering facility with WestPark Capital

## Summary
- ProPhase Labs entered an At-the-Market Sales Agreement with WestPark Capital on Oct 9, 2025, to sell common stock from time to time.
- Agent receives 3.0% commission on gross proceeds; company reimburses certain expenses.
- Sales made under existing effective S-3 registration statement (No. 333-283182) declared effective Nov 20, 2024.
- Company is not obligated to sell any shares; may suspend or terminate agreement at any time.

## SEC filing metadata
- accession: 0001493152-25-018123
- form_type: 8-K
- ticker: PRPH
- cik: 0000868278
- company_name: ProPhase Labs, Inc.
- filed_at: 2025-10-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/868278/000149315225018123/0001493152-25-018123-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/868278/000149315225018123/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-018123
- JSON: https://secwatch.observer/filing/0001493152-25-018123.json
- Plain text: https://secwatch.observer/filing/0001493152-25-018123.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.